2. UroToday Home
  3. Video Lectures

Localized Prostate Cancer Videos

NCCN Guidelines 2022 - Prostate Cancer on Comparison of Treatment Options for Localized Disease + Local Therapies + Disease Monitoring - Zachary Klaassen and Chris Wallis
January 17, 2022
Details
Treatment-Related Regret Among Men With Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
December 16, 2021
Details
High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack
November 18, 2021
Details
NCCN Prostate Cancer Clinical Practice Guidelines on Risk Stratification for Clinically Localized Prostate Cancer – Christopher Wallis & Zachary Klaassen
November 10, 2021
Details
Improving the Quality of Care for Men in Michigan With Prostate Cancer, the MUSIC Collaborative, a Focus on the G-MINOR and G-MAJOR Trials – Todd Morgan
August 30, 2021
Details
Personalized Hormone Therapy with Post-Operative Radiation Therapy and Validation of the Decipher Genomic Classifier in SAKK 09/10 Trial - Dan Spratt and Alan Dal Pra
August 18, 2021
Details
When to Add ADT to Early or Late Salvage Radiation - Dan Spratt
August 18, 2021
Details
Clinical Case Discussions - "Rising PSA 18 Months Post RP and Timing of Radiotherapy" - Ashley Ross, Alan Dal Pra, and Dan Spratt
August 18, 2021
Details
Prostate Cancer Screening and Shared Decision Making in the Veterans Health Administration - Stacy Loeb
August 11, 2021
Details
PCORI-Funded Initiative Evidence Gaps To Guide Future Research on the Use of Active Surveillance for Prostate Cancer – M. Minhaj Siddiqu
July 18, 2021
Details
Prognostic Utility of Decipher® Prostate Genomic Classifier in the SAKK 09/10 Phase III Trial - Alan Dal Pra
June 17, 2021
Details
Prostate Cancer Modeling: The CISNET Prostate Group - Ruth Etzioni
May 9, 2021
Details
A Systematic Review of the Decipher® Genomic Classifier in Prostate Cancer - Ashley Ross & Daniel Spratt
February 16, 2021
Details
Prostate Active Surveillance Study (PASS) - Daniel Lin
November 2, 2020
Details
How Can We Accelerate Clinical Trial Accrual in Localized Prostate Cancer? - Brian F. Chapin
November 13, 2020
Details
An Expert Discussion on Gleason 6 (Grade Group 1) Prostate Cancer - Scott Eggener 
October 4, 2020
Details
DASL-HiCAP (ANZUP1801): The Impact of Darolutamide on Standard Therapy for Localized Very High-risk Cancer of the Prostate - Christopher Sweeney
July 28, 2020
Details
The Role of Neoadjuvant Therapy for Patients with Localized Prostate Cancer - Rana R. McKay
June 8, 2020
Details
Active Surveillance for Low-Risk Prostate Cancer - Laurence Klotz and Peter Carroll
March 13, 2020
Details
Study of Baseline PSA Screening of Men (45 years old) - Peter Albers
December 30, 2019
Details
Radiation Therapy Advances and Technology Overview - Daniel Spratt
December 16, 2019
Details
Epidemiologic Outcomes of Prostate Cancer Patients Undergoing Active Surveillance - Sigrid Carlsson
November 11, 2019
Details
Exercise vs. Usual Care Among Men Opting for Active Surveillance for Prostate Cancer - June Chan
January 15, 2020
Details
Increasing Rates of Active Surveillance as the Standard of Care in Men with Low Risk Prostate Cancer- Matthew Cooperberg
November 6, 2019
Details
ProVent Trial for Newly Diagnosed Prostate Cancer - Benjamin Lowentritt
February 7, 2019
Details
Engagement in Long-Term Physical Activity and Lowering the Risk of Advanced Prostate Cancer - Lorelei Mucci
January 29, 2019
Details
Focal Therapy: Ready or Not - Herbert Lepor
December 1, 2018
Details
EXTEND, Phase 2 Trial Evaluating the Safety and Efficacy of Exercise Training in Men with Hormone Naïve Prostate Cancer - Mike Harrison
October 29, 2018
Details
Long-Term Outcomes of Active Surveillance for Prostate Cancer - Interview with Sigrid Carlsson
June 12, 2018
Details
The Men’s Eating and Living (MEAL) Study, Diet Intervention in Men on Active Surveillance for Prostate Cancer - Interview with J. Kellogg Parsons
May 21, 2018
Details
Active Surveillance: Who is the Right Patient? - Matt Cooperberg
April 17, 2018
Details
email news signup